Published in J Clin Pathol on March 01, 2001
Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol (2009) 1.14
Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clin Diagn Lab Immunol (2002) 1.04
Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens. Clin Diagn Lab Immunol (2004) 0.88
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology. Clin Rev Allergy Immunol (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol (1966) 7.40
Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med (1975) 5.00
A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med (1988) 2.98
The L. E. cell and the L. E. serum factors. Bull N Y Acad Med (1959) 2.12
Definition of the antigenic polypeptides in the Sm and RNP ribonucleoprotein complexes. Biochem Biophys Res Commun (1981) 1.91
Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody. J Clin Invest (1984) 1.90
Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein. Arthritis Rheum (1991) 1.85
Quantitation and detection of isotypes of anti-SS-B antibodies by ELISA and Farr assays using affinity purified antigens. An approach to the investigation of Sjögren's syndrome and systemic lupus erythematosus. Arthritis Rheum (1983) 1.48
Evaluation of recombinant Ro/SSA, La/SSB, Sm, and U1 RNP autoantigens in clinical diagnosis. J Clin Lab Anal (1995) 1.45
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum (1990) 1.28
Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis. Br Med J (1977) 1.23
The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods (1991) 1.19
Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin Exp Immunol (1985) 1.13
Autoimmune response to the Ro/SSA particle is directed to the human antigen. Clin Exp Immunol (1989) 1.09
The detection of anti-Ro/SS-A and anti-La/SS-B antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays. J Immunol Methods (1990) 1.08
Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol (1988) 1.08
Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting. Arthritis Rheum (1997) 1.07
Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. J Immunol Methods (1998) 1.01
Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol (1993) 1.01
The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992. Clin Exp Rheumatol (1993) 0.96
Autoantibodies to the Ro/SSA autoantigen are conformation dependent. II: Antibodies to the denatured form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule. Autoimmunity (1992) 0.93
Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum (1996) 0.90
Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens. Ann Rheum Dis (1988) 0.89
A comparison of ELISA assays as routine diagnostic test for detection of autoantibodies against extractable nuclear antigens. Clin Biochem (1999) 0.88
Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Clin Exp Rheumatol (1992) 0.82
Rheumatic autoantibodies in the sera of patients with paraproteins. Clin Exp Rheumatol (1994) 0.82
Detection of antibodies to double stranded DNA and extractable nuclear antigen. J Clin Pathol (1987) 0.80
Antibody to extractable nuclear antigen in the rheumatic diseases. J Rheumatol (1978) 0.80
Detection of antibody against extractable nuclear antigen by an enzyme-linked immuno-sorbent assay. Results from patients with rheumatic and internal medical diseases. Allergy (1985) 0.80
The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies. Clin Exp Immunol (1989) 0.79
Detection of anti-extractable nuclear antigens in connective tissue diseases: comparison between passive hemagglutination, counterimmunoelectrophoresis and double immunodiffusion. Ric Clin Lab (1985) 0.78
Simple dot-blot method evaluated for detection of antibodies against extractable nuclear antigens. Clin Chem (1997) 0.78
The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci (1977) 0.77
Comparative evaluation of various methods of detecting antibodies against soluble nuclear antigens. Arch Immunol Ther Exp (Warsz) (1982) 0.77
Gliadin and reticulin antibodies in childhood coeliac disease. Lancet (1983) 2.11
New immunofluorescent blood test for gluten sensitivity. Arch Dis Child (1981) 1.88
Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut (1987) 1.79
IgA anti-gliadin antibodies in coeliac disease. Clin Exp Immunol (1981) 1.78
Binding of wheat gliadin in vitro to reticulum in normal and dermatitis herpetiformis skin. J Invest Dermatol (1981) 1.57
Misdiagnosis of hereditary angio-oedema type 1 and type 2. Br J Dermatol (2003) 1.50
Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr (1985) 1.47
Anti-reticulin antibodies: useful adjunct to histopathology in diagnosing celiac disease, especially in a developing country. J Pediatr Gastroenterol Nutr (1989) 1.47
Arthritis and coeliac disease. Ann Rheum Dis (1985) 1.43
Anti-gliadin antibodies and small intestinal mucosal damage in dermatitis herpetiformis. Br J Dermatol (1981) 1.35
Studies on reticulin. I: Serological and immunohistological investigations of the occurrence of collagen type III, fibronectin and the non-collagenous glycoprotein of Pras and Glynn in reticulin. Br J Exp Pathol (1982) 1.13
IgA in dermatitis-herpetiformis skin is dimeric. Lancet (1982) 1.11
The immunopathogenesis of meningococcal disease. J Clin Pathol (2003) 1.07
Anti-reticulin antibody in gluten sensitive enteropathy. Q J Med (1993) 1.06
Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies-the antibody trinity of coeliac disease. Clin Exp Immunol (1999) 1.04
Linear IgA disease in adults. Br J Dermatol (1982) 1.01
IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy. J Clin Pathol (1999) 0.98
Autoantibodies against gut epithelium in child with small-intestinal enteropathy. Lancet (1982) 0.98
Coeliac disease and unfavourable outcome of pregnancy. Gut (2000) 0.97
Immunoglobulins and immunoglobulin subclasses in the elderly. Ann Clin Biochem (2003) 0.96
Identifying immunoglobulin-A--deficient children and adults does not necessarily help the serologic diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (1999) 0.94
Antigliadin and antireticulin antibodies in screening for coeliac disease. Lancet (1987) 0.92
Iron-deficiency anaemia in premenopausal women. Lancet (1999) 0.90
Studies on the significance of the R1 anti-reticulin antibody associated with gluten sensitivity. Int Arch Allergy Appl Immunol (1985) 0.90
Tissue transglutaminase antibodies in dermatitis herpetiformis. Gastroenterology (1999) 0.88
Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis. Br J Dermatol (1984) 0.88
HLA Cw*06 is not essential for streptococcal-induced psoriasis. Br J Dermatol (2006) 0.86
Anaemia in blood donors is not being properly investigated. BMJ (1999) 0.85
DNA polymorphisms of the complement C6 and C7 genes. Ann Hum Genet (1995) 0.85
Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase. J Immunol Methods (1999) 0.85
Type 1 diabetes mellitus masking primary antibody deficiency. J Clin Pathol (2000) 0.84
The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity. Diabetes Care (2001) 0.83
Does the reticulin binding property of cereal proteins demonstrable in vitro have pathogenetic significance for coeliac disease? Gut (1985) 0.83
Coeliac disease, anaemia and pregnancy. Clin Lab (2001) 0.83
Immunoglobulin A deficiency on serological coeliac screening: an opportunity for early diagnosis of hypogammaglobulinaemia. Ann Clin Biochem (2012) 0.83
Ataxia, peripheral neuropathy, and anti-gliadin antibody. Guilt by association? J Neurol Neurosurg Psychiatry (2005) 0.82
Coeliac disease as cause of protracted diarrhoea in Indian children. Lancet (1988) 0.82
c-ANCA as a marker of Wegener's disease. Lancet (1996) 0.82
Diagnosing coeliac disease by rectal gluten challenge: a prospective study based on immunopathology, computerized image analysis and logistic regression analysis. Clin Sci (Lond) (2001) 0.80
Thymoma, autoimmunity and fatal immunodeficiency. QJM (2000) 0.80
Failure of R1 type anti-reticulin antibody to react with fibronectin, collagen type III or the non-collagenous reticulin component (NCRC). Clin Exp Immunol (1984) 0.79
Echocardiographic abnormalities in primary antibody deficiency. Postgrad Med J (2004) 0.78
Pitfalls in the performance and interpretation of clinical immunology tests. J Clin Pathol (2008) 0.77
Unscrambling Egg Allergy: The Diagnostic Value of Specific IgE Concentrations and Skin Prick Tests for Ovomucoid and Egg White in the Management of Children with Hen's Egg Allergy. ISRN Allergy (2012) 0.77
A recipient of immunoglobulin from a donor who developed vCJD. Vox Sang (2009) 0.77
Gliadin in bullous pemphigoid. Lancet (1981) 0.76
A practical approach to the use of intravenous immunoglobulin in neurological disease. Eur Neurol (1998) 0.76
Measurement of immune complexes is not useful in routine clinical practice. Ann Clin Biochem (2000) 0.76
Life-threatening acute pulmonary haemorrhage in primary Sjögren's syndrome with cryoglobulinaemia. Scand J Rheumatol (2005) 0.76
Dermatitis herpetiformis and neurological dysfunction. J Neurol Neurosurg Psychiatry (2002) 0.75
Lumbar punctures and meningitis. Pediatrics (2002) 0.75
Pneumocystis carinii, cytomegalovirus, and severe transient immunodeficiency. J Clin Pathol (2003) 0.75
Immunofluorescent patterns associated with ANCA. J Clin Pathol (1999) 0.75
Missed clues and delayed diagnosis of immunodeficiency. Lancet (1997) 0.75
Anti-gliadin antibodies in dermatitis herpetiformis. J R Soc Med (1981) 0.75
Gluten sensitivity and neurological dysfunction. Lancet (1996) 0.75
R1 anti-reticulin antibody as marker of subclinical gluten enteropathy. Lancet (1992) 0.75
Failure of intradermal skin testing with gluten to produce delayed hypersensitivity reactions in patients with dermatitis herpetiformis. Br J Dermatol (1995) 0.75
Skin biopsies in relatives of patients with dermatitis herpetiformis. Acta Derm Venereol (1983) 0.75
Ethics approvals and quagmires. Clin Med (2003) 0.75
Antigliadin and antireticulin antibodies in coeliac disease. Lancet (1988) 0.75
HLA and kidney transplantation. J Clin Pathol (2010) 0.75
Severe hypotension associated with angiotensin-converting enzyme inhibition in anaesthesia. Anaesth Intensive Care (1998) 0.75
Wiskott-Aldrich syndrome, vasculitis and critical aortic dilatation. Acta Paediatr (2001) 0.75